• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Scientist's Selfless Act Could Provide a Lead for Treating TNBC

Article

Dr Koss refused preoperative chemotherapy to avoid damaging her virulent cells, which could later be cultured and could likely provide therapeutic leads.

This year, an estimated 232,000 American women will learn they have breast cancer. On April 28, Kim Koss found out she was one of them.

She took the news as many women do, with shock, fear and sadness. Two weeks later, the news got worse. Hers was a triple-negative cancer, a fast-growing form not fueled by the estrogen, progesterone or HER2/neu gene that are at play in most breast cancers. It meant commonly used drugs and treatments have little benefit for her.

The implications were not lost on Koss, who has a doctorate in biomedical sciences and years of experience with cellular research. Her prognosis was listed as “poor.” “I knew what I was facing,” she says.

It could have immobilized her. Less than a month after her diagnosis, though, her scientist side took charge of what the patient side could not.

Original report: http://cin.ci/1m5Jkn4

Source: Cincinatti

Related Videos
Will Shapiro
Mila Felder, MD, FACEP
Kiana Mehring, MBA, director of strategic partnerships, managed care at Florida Cancer Specialists & Research Institute (FCS)
Miriam J. Atkins, MD, FACP, president of the Community Oncology Alliance (COA) and physician and partner of AO Multispecialty Clinic in Augusta, Georgia.
Dr Lucy Langer
Edward Arrowsmith, MD, MPH
Dr Kathi Mooney
Tiago Biachi de Castria, MD, PhD, Moffitt Cancer Center
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.